Credit Suisse Ag Meridian Bioscience Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$31.15 - $33.39 $157,868 - $169,220	-5,068 Reduced 3.63%	134,566 $4.47 Million
Q3 2022 Nov 10, 2022	BUY	$30.9 - $33.55 $3.26 Million - $3.54 Million	105,441 Added 308.37%	139,634 $4.4 Million
Q2 2022 Aug 12, 2022	SELL	$23.75 - $31.69 $101,602 - $135,569	-4,278 Reduced 11.12%	34,193 $1.04 Million
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $86,150 - $116,219	4,314 Added 12.63%	38,471 $998,000
Q4 2021 Feb 14, 2022	BUY	$17.46 - $21.61 $39,896 - $49,378	2,285 Added 7.17%	34,157 $697,000
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $57,064 - $74,002	-3,289 Reduced 9.35%	31,872 $614,000
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $68,816 - $108,210	-3,821 Reduced 9.8%	35,161 $780,000
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $168,829 - $255,380	-8,544 Reduced 17.98%	38,982 $1.02 Million
Q4 2020 Feb 12, 2021	BUY	$15.73 - $21.66 $340,460 - $468,809	21,644 Added 83.63%	47,526 $888,000
Q3 2020 Nov 13, 2020	SELL	$13.54 - $26.41 $38,765 - $75,611	-2,863 Reduced 9.96%	25,882 $439,000
Q2 2020 Aug 12, 2020	BUY	$7.84 - $23.29 $21,959 - $65,235	2,801 Added 10.8%	28,745 $669,000
Q1 2020 May 13, 2020	SELL	$5.57 - $11.5 $108,152 - $223,295	-19,417 Reduced 42.81%	25,944 $218,000
Q4 2019 Feb 12, 2020	BUY	$7.9 - $10.14 $115,434 - $148,165	14,612 Added 47.52%	45,361 $444,000
Q3 2019 Nov 12, 2019	BUY	$9.17 - $12.01 $27,418 - $35,909	2,990 Added 10.77%	30,749 $292,000
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $358,452 - $579,849	-32,946 Reduced 54.27%	27,759 $329,000
Q1 2019 May 14, 2019	BUY	$15.51 - $17.61 $118,201 - $134,205	7,621 Added 14.36%	60,705 $1.07 Million
Q4 2018 Feb 13, 2019	BUY	$14.52 - $19.72 $177,826 - $241,510	12,247 Added 29.99%	53,084 $921,000
Q3 2018 Nov 13, 2018	SELL	$14.85 - $16.35 $1.51 Million - $1.66 Million	-101,606 Reduced 71.33%	40,837 $608,000
Q2 2018 Aug 14, 2018	SELL	$13.8 - $16.8 $103,886 - $126,470	-7,528 Reduced 5.02%	142,443 $2.27 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $21,086 - $24,753	1,528 Added 1.03%	149,971 $2.13 Million
Q4 2017 Feb 14, 2018	SELL	$13.55 - $15.8 $211,827 - $247,001	-15,633 Reduced 9.53%	148,443 $2.08 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $395,497 - $421,961	29,405 Added 21.83%	164,076 $2.35 Million
Q2 2017 Aug 14, 2017	BUY	N/A	134,671	134,671 $2.12 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account